Literature DB >> 12089196

IgG anti-transglutaminase autoantibodies in systemic lupus erythematosus and Sjögren syndrome.

Danilo Villalta, Nicola Bizzaro, Elio Tonutti, Renato Tozzoli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089196

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  7 in total

1.  A patient with a polyglandular autoimmune syndrome involving the salivary glands, thyroid, intestine, and pancreas.

Authors:  Alan L Buchman; Sambasiva M Rao
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

2.  Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population.

Authors:  Dominica Gidrewicz; Kathryn Potter; Cynthia L Trevenen; Martha Lyon; J Decker Butzner
Journal:  Am J Gastroenterol       Date:  2015-03-31       Impact factor: 10.864

Review 3.  Celiac disease in children and adolescents: special considerations.

Authors:  Kimberly P Newton; Shereen A Singer
Journal:  Semin Immunopathol       Date:  2012-05-02       Impact factor: 9.623

4.  IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis.

Authors:  N Bizzaro; D Villalta; E Tonutti; A Doria; M Tampoia; D Bassetti; R Tozzoli
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

Review 5.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

6.  High prevalence of celiac disease among Saudi children with type 1 diabetes: a prospective cross-sectional study.

Authors:  Abdulrahman Al-Hussaini; Nimer Sulaiman; Musa Al-Zahrani; Ahmed Alenizi; Imad El Haj
Journal:  BMC Gastroenterol       Date:  2012-12-23       Impact factor: 3.067

7.  Anti-actin IgA antibodies identify celiac disease patients with a Marsh 3 intestinal damage among subjects with moderate anti-TG2 levels.

Authors:  Enrico Schirru; Fabrice Danjou; Lucia Cicotto; Rossano Rossino; Maria Doloretta Macis; Rosanna Lampis; Rita-Désirée Jores; Mauro Congia
Journal:  Biomed Res Int       Date:  2013-09-05       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.